These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22329655)

  • 61. Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease.
    Uddin MS; Al Mamun A; Rahman MA; Behl T; Perveen A; Hafeez A; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
    Curr Top Med Chem; 2020; 20(26):2380-2390. PubMed ID: 32479244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mitophagy pathways and Alzheimer's disease: From pathogenesis to treatment.
    Pan XJ; Misrani A; Tabassum S; Yang L
    Mitochondrion; 2021 Jul; 59():37-47. PubMed ID: 33872797
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of tetrahydrocarbazoles as novel multifactorial drug candidates for treatment of Alzheimer's disease.
    Honarnejad K; Daschner A; Gehring AP; Szybinska A; Giese A; Kuznicki J; Bracher F; Herms J
    Transl Psychiatry; 2014 Dec; 4(12):e489. PubMed ID: 25514752
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
    Soejima N; Ohyagi Y; Nakamura N; Himeno E; Iinuma KM; Sakae N; Yamasaki R; Tabira T; Murakami K; Irie K; Kinoshita N; LaFerla FM; Kiyohara Y; Iwaki T; Kira J
    Curr Alzheimer Res; 2013 Jan; 10(1):11-20. PubMed ID: 22950910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Golgi apparatus and protein trafficking in Alzheimer's disease.
    Baloyannis SJ
    J Alzheimers Dis; 2014; 42 Suppl 3():S153-62. PubMed ID: 24946873
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting Abeta and tau in Alzheimer's disease, an early interim report.
    Golde TE; Petrucelli L; Lewis J
    Exp Neurol; 2010 Jun; 223(2):252-66. PubMed ID: 19716367
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endoplasmic reticulum stress mediates JNK-dependent IRS-1 serine phosphorylation and results in Tau hyperphosphorylation in amyloid β oligomer-treated PC12 cells and primary neurons.
    Zhang X; Tang S; Zhang Q; Shao W; Han X; Wang Y; Du Y
    Gene; 2016 Aug; 587(2):183-93. PubMed ID: 27185631
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer's disease.
    Singh R; Kaur N; Dhingra N; Kaur T
    Int J Neurosci; 2023 Jul; 133(7):714-734. PubMed ID: 34402740
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease.
    Mu JS; Lin H; Ye JX; Lin M; Cui XP
    Mol Med Rep; 2015 Sep; 12(3):3862-3868. PubMed ID: 26016457
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.
    Takeda S
    Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
    Pan K; Chen S; Wang Y; Yao W; Gao X
    Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calbindin-D
    Jung EM; Yoo YM; Park SY; Ahn C; Jeon BH; Hong EJ; Kim WY; Jeung EB
    Cell Physiol Biochem; 2020 May; 54(3):438-456. PubMed ID: 32357291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative Gene-Expression Analysis of Alzheimer's Disease Progression with Aging in Transgenic Mouse Model.
    Abid NB; Naseer MI; Kim MO
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A three-dimensional human neural cell culture model of Alzheimer's disease.
    Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
    Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
    [TBL] [Abstract][Full Text] [Related]  

  • 78. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
    Madav Y; Wairkar S; Prabhakar B
    Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.
    Rüb U; Stratmann K; Heinsen H; Seidel K; Bouzrou M; Korf HW
    J Alzheimers Dis; 2017; 57(3):683-696. PubMed ID: 28269779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.